p53通过脂胆氨酸抑制了脂滴驱动的瘤发生
Xiuduan Xu1,2, Jianqin Wang2, Li Xu2
1State Key Laboratory of Molecular Oncology, School of Life Sciences, Tsinghua University, and Tsinghua-Peking Center for Life Sciences, Beijing, China.
The Journal of clinical investigation
|January 9, 2024
概括
瘤抑制剂p53通过肯尼迪通路调节胆代谢,控制脂质滴的生长和瘤发生. 失去p53会破坏这个过程,促进肝硬化和癌症的进展.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 代谢研究研究 代谢研究
背景情况:
- 胆缺乏与肝病和癌症风险增加有关.
- 瘤抑制剂p53在细胞平衡和癌症预防中起着至关重要的作用.
- 脂质滴 (LDs) 是细胞器官,参与脂质储存和代谢,对各种疾病有影响.
研究的目的:
- 研究瘤抑制剂p53在胆代谢中的作用及其对脂质滴滴恒温和瘤产生的影响.
- 阐明p53在胆有限条件下影响肯尼迪通路和酸丁胆生物合成的分子机制.
主要方法:
- 在没有胆的饮食中对细胞进行RNA测序 (RNA-Seq) 分析.
- 研究p53对肯尼迪通路酶PCYT1B的调节.
- 评估脂质滴滴动态,包括凝聚和脂解.
- 在体内和体外研究评估p53和肯尼迪通路在瘤细胞脂质代谢和生长中的作用.
主要成果:
- p53调节PCYT1B,将胆引导到酸丁胆 (PC) 合成,并在胆饥饿期间防止LD凝聚.
- 失去p53会损害这种反应,导致肝脏肥胖症并促进瘤发生.
- 在p53或肯尼迪通路的缺陷增加激素敏感脂酶在LDs的局部化,提供脂肪酸,燃料瘤生长.
- 恢复PCYT1B表达或PC水平可以逆转胆枯竭和p53损失的影响.
结论:
- 瘤抑制剂p53是肯尼迪通路和脂质滴体恒温的关键调节者,对于预防胆缺乏下肝硬化和瘤发生是必不可少的.
- 失去p53会破坏胆代谢,导致异常的LD生长,并为瘤细胞提供代谢燃料来源.
- 准肯尼迪通路或恢复PC水平可能为与p53功能障碍和改变脂质代谢相关的癌症提供治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Synthesis of Phosphatidylcholine in the ER Membrane
3.1K
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
3.1K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


